Malaysia MDA Updates Medical Device Definitions, Special Access, & Legacy Device Rules 

In March 2026, the Medical Device Authority Malaysia (MDA) published three significant guidance updates affecting medical device regulation under the Medical Device Act 2012 (Act 737): 

• Second Edition of “Definition of Medical Devices” (MDA/GD/0006) 
• Third Edition of “Guidance on Import and/or Supply of Unregistered Medical Devices under Special Access Exemption Application” (MDA/GD/0043) 
• First Edition of “Guidance on Application for Confirmation Status of Obsolete and Discontinued Medical Devices” (MDA/GD/0071) 

The publications address medical device definitions, special access exemptions for unregistered medical devices, and the management of obsolete and discontinued devices in Malaysia. 

Updated Guidance on the Definition of Medical Devices 

The most far-reaching update is the publication of the Second Edition of the guidance “Definition of Medical Devices” (MDA/GD/0006), which provides important clarification on how products are classified and regulated in Malaysia. 

The revised guidance reinforces that a medical device is defined primarily by its intended use, including purposes such as diagnosis, monitoring, or treatment. Products achieving their primary intended action through pharmacological, immunological, or metabolic means remain outside medical device scope. 

For manufacturers and distributors, the revised definitions are important because they may affect classification decisions, registration obligations, and product portfolio assessments. 

MDA Clarifies Accessories, Components, and Spare Parts 

A key focus of the revision is the clearer distinction between accessories, components, and spare parts — an area that has historically created uncertainty for industry. 

Under the updated guidance: 

• Accessories are explicitly recognized as medical devices in their own right and may require separate classification and registration.  
• Components used during manufacturing are not regulated as standalone medical devices.  
• Spare parts used for maintenance or replacement are generally excluded from regulation provided they do not alter the intended purpose or performance of the original device.  

These clarifications are expected to help reduce inconsistent interpretation and support more consistent classification decisions. 

Updated Special Access Rules for Unregistered Medical Devices 

Alongside the revised definition guidance, MDA also issued the Third Edition of “Guidance on Import and/or Supply of Unregistered Medical Devices under Special Access Exemption” (MDA/GD/0043). 

The updated framework refines Malaysia’s special access pathway for unregistered medical devices used in exceptional clinical situations where no suitable registered alternative is available. 

The mechanism operates under the Medical Device (Exemption) Order 2024 and allows controlled access to unregistered devices under defined regulatory conditions. 

Expanded Eligibility Criteria for Special Access 

The revised guidance clearly identifies four scenarios where special access exemptions may apply: 

• Emergency situations  
• Compassionate use cases  
• Supply disruption or stock-out situations  
• Devices offering improved clinical outcomes due to design or functionality  

This clarification is particularly relevant for manufacturers supplying innovative technologies, highly specialized devices, or products facing temporary registration or supply limitations. 

Transition to the MeDC@St Submission System 

MDA has also modernized the application process by requiring submissions through the MeDC@St electronic platform. 

Applications must include: 

• Device information and intended use  
• Clinical justification  
• Supporting regulatory approvals from other jurisdictions  
• Documentation from qualified medical practitioners  

An administrative fee of RM 300 applies. MDA states that complete applications are generally reviewed within seven working days, and approved exemptions remain valid for six months. 

Compliance Obligations Remain Strict 

Despite the exemption pathway, regulatory controls continue to apply. 

Approved devices: 

• Require pre-approval before importation or supply  
• Must carry “Special Access” labeling  
• May only be used for the approved clinical purpose  
• Remain subject to adverse event reporting and post-market monitoring obligations  

Following expiry, devices must either be exported, disposed of, or transitioned into the standard registration pathway. 

A New Formal Framework for Obsolete and Discontinued Medical Devices 

MDA has also published the First Edition of “Guidance on Application for Confirmation Status of Obsolete and Discontinued Medical Devices” (MDA/GD/0071), establishing a formal pathway for managing legacy devices that remain in clinical use after commercial discontinuation. 

The guidance addresses a practical challenge in healthcare settings where older devices continue operating despite no longer being manufactured or supplied. 

New Exemption Mechanism for Legacy Devices 

Under Act 737, only registered medical devices may be placed on the market. However, many healthcare facilities continue relying on aging systems that remain functional and clinically necessary. 

Supported by the Medical Device (Exemption) Order 2024, the new guidance establishes a controlled exemption pathway that allows continued use of certain legacy devices under defined conditions. 

Under the guidance: 

• “Obsolete devices” refer to outdated technologies no longer manufactured 
• “Discontinued devices” refer to products no longer supplied in the market 

Application Requirements 

To obtain exemption status, establishments must submit: 

• Manufacturer declarations  
• Healthcare facility declarations  
• Maintenance or transition plans  

Eligible devices must: 

• Have been previously registered  
• Be formally declared obsolete or discontinued by the manufacturer  
• Remain operational within healthcare facilities  

An administrative fee of RM 300 applies, and MDA states that applications are generally reviewed within approximately 10 working days. 

If approved, MDA issues an exemption letter valid for three years, confirming that the device is exempt from registration requirements. 

Under the exemption: 

• Use is limited to existing healthcare environments  
• Establishments must maintain documentation records  
• Post-market surveillance obligations apply for at least five years  
• MDA may require discontinuation if safety concerns arise  

What These Updates Mean for Foreign Medical Device Companies

The latest MDA guidance updates introduce important changes across several areas of Malaysia’s medical device regulatory framework, with implications spanning product classification, registration planning, emergency import pathways, legacy device management, and post-market compliance obligations. 

Companies operating in Malaysia should assess how the revised requirements may affect existing registrations, product portfolios, import procedures, and lifecycle management processes — particularly for accessories, unregistered devices supplied under special access, and obsolete or discontinued products still in clinical use..

At Cisema, we support international medical device companies with regulatory strategy, product registration, authorized representation, and compliance management in Malaysia and across Southeast Asia.

For support with medical device compliance and registration in Malaysia, contact Cisema today.

Further Information

• Explore Cisema’s Medical Device Registration Services in Malaysia‍
• Read our Guide to Medical Device Registration in Malaysia

References 

1. Publication of Third Edition of Guidance Document on Import and/or Supply of Unregistered Medical Devices Under Special Access Exemption Application
2. Publication of Second Edition of Guidance Document on Definition of Medical Devices
3. Publication of First Edition of Guidance Document on Application for Confirmation Status of Obsolete and Discontinued Medical Devices